144 related articles for article (PubMed ID: 8419114)
1. Cyclosporine treatment for dermatomyositis/polymyositis.
Mehregan DR; Su WP
Cutis; 1993 Jan; 51(1):59-61. PubMed ID: 8419114
[TBL] [Abstract][Full Text] [Related]
2. Treatment of polymyositis and dermatomyositis.
Kaye SA; Isenberg DA
Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Maeda K; Kimura R; Komuta K; Igarashi T
Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis.
Gruhn WB; Diaz-Buxo JA
J Rheumatol; 1987 Oct; 14(5):1045-7. PubMed ID: 3323505
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A as first choice therapy for dermatomyositis.
Grau JM; Herrero C; Casademont J; Fernández-Solà J; Urbano-Márquez A
J Rheumatol; 1994 Feb; 21(2):381-2. PubMed ID: 8182665
[No Abstract] [Full Text] [Related]
7. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
Schiopu E; Phillips K; MacDonald PM; Crofford LJ; Somers EC
Arthritis Res Ther; 2012 Jan; 14(1):R22. PubMed ID: 22284862
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.
Qushmaq KA; Chalmers A; Esdaile JM
J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676
[TBL] [Abstract][Full Text] [Related]
9. Rituximab as therapy for refractory polymyositis and dermatomyositis.
Noss EH; Hausner-Sypek DL; Weinblatt ME
J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application.
Danieli MG; Pettinari L; Moretti R; Logullo F; Gabrielli A
Autoimmun Rev; 2011 Jan; 10(3):144-9. PubMed ID: 20858553
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy.
Sánchez-Fernández SÁ; Carrasco Fernández JA; Rojas Vargas LM
Reumatol Clin; 2013; 9(2):117-9. PubMed ID: 22771272
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
Danieli MG; Malcangi G; Palmieri C; Logullo F; Salvi A; Piani M; Danieli G
Ann Rheum Dis; 2002 Jan; 61(1):37-41. PubMed ID: 11779756
[TBL] [Abstract][Full Text] [Related]
13. [Coexistence of hypothyroidism with polymyositis or dermatomyositis].
Lukjanowicz M; Bobrowska-Snarska D; Brzosko M
Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis.
Wenzel J; Bieber T
J Rheumatol; 2001 Sep; 28(9):2139. PubMed ID: 11550990
[No Abstract] [Full Text] [Related]
15. Adjunctive use of hydroxychloroquine in childhood dermatomyositis.
Olson NY; Lindsley CB
J Rheumatol; 1989 Dec; 16(12):1545-7. PubMed ID: 2483176
[TBL] [Abstract][Full Text] [Related]
16. Strength in polymyositis and dermatomyositis: best outcome in patients treated early.
Fafalak RG; Peterson MG; Kagen LJ
J Rheumatol; 1994 Apr; 21(4):643-8. PubMed ID: 8035387
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of polymyositis and dermatomyositis.
Murthy JM
Neurol India; 2010; 58(1):3-5. PubMed ID: 20228455
[No Abstract] [Full Text] [Related]
18. Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report.
Chang HK; Lee DH
J Korean Med Sci; 2003 Feb; 18(1):131-4. PubMed ID: 12589104
[TBL] [Abstract][Full Text] [Related]
19. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
Efthimiou P; Schwartzman S; Kagen LJ
Ann Rheum Dis; 2006 Sep; 65(9):1233-6. PubMed ID: 16476710
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
Woo TY; Callen JP; Voorhees JJ; Bickers DR; Hanno R; Hawkins C
J Am Acad Dermatol; 1984 Apr; 10(4):592-600. PubMed ID: 6715608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
